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Abstract The chemiluminescence (CL) of oxidation of non-
steroidal anti-inflammatory drugs (NSAIDs) by Ce(IV) ions,
was recorded in the presence and absence europium(III) ions,
in solution of pH~4 of solution. Kinetic curves and CL
emissionspectraoftheallstudiedsystemswerediscussed.CL
of measurable intensity was observed in the Ce(IV)–NP–Eu
(III) reaction system only in acidic solutions. The CL
spectrum rcegistered for this system shows emission bands,
typical of Eu(III) ions, with maximum at l~600 nm. The
chemiluminescent method, based on Eu(III) emission in
reaction system of NP-Ce(IV)–Eu(III) in acid solution was
therefore used for the determination of naproxen in mixture
of non-steroidal anti-inflammatory drugs.
Keywords Chemiluminescence.Europium.Non-steroidal
anti-inflammatory drugs
Introduction
Naproxen(NP), ibuprofen(IB) and indomethacin (IM) are
non-steroidal anti-inflammatory drugs (NSAID). Chemically,
NP and IB belong to the 2-arylpropionic acid family, whereas
IM belongs to the class of arylacetic acid. The NSAID as a
group are diverse in chemical structure but are consistent in
their ability to inhibit the enzyme cyclooxygenase, regarded
as a marker for inflammation [1]. The complexation
processes of naproxen(NP) or ibuprofen(IB) or indomethacin
(IM) with lanthanide ions depend of pH values. In acidic
solution, the degree of complexation is small [2]. The
trivalent lanthanide ions, especially Eu(III) and Tb(III),
display spectroscopic properties of high photoluminescence
efficiencies,longexcited-statelifetimesbandnarrowemission
spectra, all of which make them be widely used as analytical
luminescent probes for a variety of chemical and biological
applications [3–5].
Chemiluminescence can be achieved by direct reactions
or by energy-transfer mechanisms. The CL phenomenon
can be applied as detection technique for the monitoring of
a wide variety of compounds in diverse fields, such as
biomedical, environmental and can be considered as an
alternative to other detection modes such as: UV/Vis
spectroscopy, fluorescence [6]. In this work, the use of
sensitized chemiluminescence of lanthanide ions for
determination of naproxen in mixture of NSAIDs is
studied. It was observed that only the CL signal of the
Ce(IV)- Naproxen system was significantly increased in
the presence of Eu(III) ions.
Experimental
Ultra weak photon emission was recorded with the use of the
earlier described equipment [7]. The fluorescence spectra
were recorded using F-7000 HITACHI spectrofluorimeter.
Chemicals
All chemicals used were of analytical reagent grade and
doubly distilled water was used throughout the experi-
M. Kaczmarek (*)
Department of Rare Earths, Faculty of Chemistry, Adam
Mickiewicz University,
Grunwaldzka 6,
60-780 Poznań, Poland
e-mail: mkaczmar@amu.edu.pl
J Fluoresc (2011) 21:2201–2205
DOI 10.1007/s10895-011-0923-2ments. Naproxen sodium and indomethacin were from
Sigma, ibuprofen sodium was from Fluka.
Their stock standard solutions (2×10
−3 molL
−1) were
prepared by dissolving appropriate amount of naproxen
sodium and ibuprofen sodium in water and diluting to
100 ml with water. A stock standard solution of indometh-
acin (6×10
−4 molL
−1) was prepared by dissolving an
appropriate amount of IM with 0.1 molL
−1 hydrochloric
acid and then diluting to 100 mL with water. Working
standard solutions of naproxen sodium were prepared of
diluted the stock solution with water.
Optimization of Experimental Conditions
The optimum conditions for the naproxen determinations
were carried out using the 1×10
−6 molL
−1 concentration of
NP. The effect of Ce(IV) concentration on the CL reaction
was examined in the range of 5.0×10
−4 to 4.0×10
−3
molL
−1 in 0.015, 0.025, 0.05, 0.15 or 0.3 molL
−1 H2SO4.
The most integrated CL light sum was obtained when the
concentration of Ce(IV) was 2.0×10
−3 mol L
−1in 0.015
molL
−1 H2SO4. For the NP-Ce(IV)-Eu(III) system, the
optimum concentration of europium(III) ions, using the
following range of concentrations 1.0×10
−4 - 1.0×10
−2
molL
−1 was determined. In the case of concentration of Eu
(III) ions above 1.0×10
−3 molL
−1 the CL light intensity
sums did not change, so as the optimal concentration of Eu
(III) ions for the determination of NP 2.0×10
−3 mol L
−1
was chosen.
Measurement Procedure
All of the chemiluminescence studies were performed in the
same manner. Solution of cerium(IV) ions was added to
solutions containing NSAID (1 mL solutions of appropriate
concentrations) or NSAID and Eu(III) ions. The experi-
ments were conducted in acidic solutions (pH~4). The total
volume was 4 mL. The determination of naproxen in water,
pharmaceutical preparations was carried out measuring the
CL light intensity sums of the reaction systems applying the
cut-off filters method, with the use of a filter transmitting
emission of l>585 nm, which was placed between the
photomultiplier and the measurement cell. CL light inten-
sity sums were calculated as the area under these curves [4].
Sample Preparation
Tablets Not less than 10 tablets were weighed and finely
powdered. Specific amounts of analyte were weighed
accurately, dissolved in water in a small beaker. The
solution was filtered, and the residue was washed with
water several times. Then it was transferred into a
2 5 0m Lc a l i b r a t e df l a s ka n dd i l u t e dt ot h es p e c i f i e d
volume with water. Working solutions were prepared by
appropriate dilution of this sample solution so that the
final analytic concentrations were within the working
range.
Ointment Accurately weighed out amount of the ointment
was dissolved in water (40 °C) and 1 mL 0.1 molL
−1 NaOH
while vigorously mixing. Next the solution was cooled in a
refrigerator, in order to separate from vaseline, and
transferred into a 100 ml calibrated flask and diluted to
volume with water. The final concentration of NP was
within the working range.
Urine
Urine samples were obtained from two healthy volunteers.
Known amounts of standard solutions of naproxen were
introduced into 1 mL of fresh urine samples. The typical
naproxen urinary concentration was 0.2–20 μg/ml [8]. This
urine sample was mixed with a 10 mL of 0.1 molL
−1 Ba
(OH)2 solution and a 9 mL of 0.1 molL
−1 ZnSO4 solution
in order to remove protein and reducing substances [9, 10].
The resulting solution was diluted to 50 mL with doubly
distilled water and centrifuged at 3000 for 15 min. The
supernatant solution was stored and maintained below 5 °C.
For analysis 1 ml of solution was used.
Results and Discussion
Effect of Presence of the Europium(III) Ions on the CL
Intensity of the Ce(IV)-NSAID Systems
The chemiluminescence of systems containing NP or IB or
IM and Ce(IV) ions as oxidizer in solution at pH~4 in the
absence and in the presence europium(III) ions were
studied. Chemiluminescence in the system NSAID-Ce(IV)
was obtained, when the concentration of NSAID was
higher than 2×10
−7 molL
−1 for NP and 4×10
−3 molL
−1
for IB and 2×10
−4 molL
−1 for IM. For all systems the
course of the kinetic curves of CL were similar, with
maximum after initiation of the reaction by introducing Ce
(IV) ions. The emission at the level of the background was
obtained in about 30 s after the reaction initiation.
Introduction of Eu(III) ions into the system NSAID-Ce
(IV) resulted in a strong increase in the emission intensity
only in the system containing naproxen without a change in
the kinetic curve character (curves 3and 4 in Fig. 1). The
intensity of CL of the systems IB-Ce(IV) and IB-Ce(IV)-Eu
(III) or IM-Ce(IV) and IM-Ce(IV)-Eu(III) were the same.
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and NP-Ce(IV) – Eu(III) were monoexponential.
Spectral analysis of the chemiluminescence in the
systems studied was performed using the method of cut-
off filters as described earlier [11]. The spectra show a
broad emission band in the range 400–600 nm, with a
maximum at l~450 nm for NP and 480 nm for IM or
420 nm for IB, which is typical of the CL systems with the
compounds containing excited carbonyl groups as emitters
[12]. The spectral distribution of CL of NP-Ce(IV)-Eu(III)
system dependent on the concentration of europium(III)
ions. The spectral distribution, observed for the molar ratio
Eu: NP=10: 1, shows a broad band at 450 nm and a second
band centered at l=600 nm (spectrum 2 in Fig. 2)
corresponding to the
5D0 →
7F1 and
5D0 →
7F2 transition
of the Eu(III) ion [13]. For higher molar ratio (Eu: NP above
100: 1) the dominant band is band typical for Eu(III) with a
maximum at l~600 nm (spectrum 4 in Fig. 2). This means
that the presence of the lanthanide ion is responsible for the
increase in the CL intensity of NP-Ce(IV)-Eu(III) system.
In order to identify the role of the lanthanide ion in the
reaction mixture NP-Ce(IV)-Eu(III), the process of Ln(III)
complexation with NP in the pH range about 4–5 was
studied. In the investigated pH region for all of the molar
ratios used (Eu: NP=10:1; 40:1 and 100:1) the lumines-
cence of Eu(III) was not observed, applying lex typical for
NP, i.e.: 270 nm, 317 nm and 327 nm. The recorded
luminescence spectra show only one large unstructured
band centered at around 353 nm (spectra 1, 2, 3 in Fig. 3),
typical for this drug [14]. Using lex=394 nm (typical for Eu
(III) ions) the same luminescence spectrum (spectrum 4 in
Fig. 3) as in the case of EuCl3 solution was obtained, which
is typical for uncomplexed Eu(III) ions [11]. This indicates
that the complex formation did not occur place in the
chemiluminescent reaction system NP-Ce(IV)-Eu(III).
As follows from Fig. 1 the presence of Eu(III) ions have
no effect on the rate of the naproxen oxidation with cerium
(IV) ions. In the chemiluminescent experimental conditions
europium(III) ions are uncomplexed and because of that a
ligand to metal transfer process cannot appear (Fig. 3). The
presence of europium(III) bands in the CL spectrum of the
NP-Ce(IV)-Eu(III) system indicates that the excitation of
Eu(III) ions in the reaction mixture is a result of the energy
transfer process from the excited product of NP oxidation to
the uncomplexed Eu(III) ions.
Oxidative decarboxylation of substituted phenylacetic
acids can be mediated by metallic and nonmetallic oxidants
or by electrolytic means [15]. When naproxen was treated
with cerium (IV) or peroxodisulfate, the product pattern
was similar to that from photolysis [16]. The major
photoproducts obtained by irradiation of the drug under
aerobic conditions are 6-methoxy-2-(1-hydroxyethyl)-
naphthalene and 6-methoxy-2-acetyl-naphthalene, and a
Fig. 2 The normalized spectral distribution of CL of the systems: NP-
Ce(IV) (spectrum 1) and NP-Ce(IV)-Eu(III) versus the molar ratio Eu
(III): NP=10: 1 (spectrum2); 40: 1 (spectrum3)and 100:1 (spectrum4).
TheconcentrationofNPwas1×10
−5 molL
−1; the initial concentration of
Ce(IV) was 2×10
−3 molL
−1,p H ~ 4
Fig. 3 The fluorescence spectrum of aqueous solution containing NP
and Eu(III) ions at pH value 4–5. The concentrations of NP was 4×
10
−4 molL
−1 and Eu(III) was 1×10
−2 molL
−1 and λexc were: 270 nm
(spectrum 1); 318 nm (spectrum 2); 327 nm (spectrum 3) and 394 nm
(spectrum 4); pH~4
Fig. 1 The kinetic curves of CL decay in the NP-Ce(IV) system versus
the concentration of NP: 6×10
−7 molL
−1 (curve 1); 2×10
−6 molL
−1
(curve 2) and NP-Ce(IV)-Eu(III) system versus the concentration of NP:
6×10
−7 molL
−1 (curve 3); 2×10
−6 molL
−1 (curve 4). The concentration
of Eu(III) ions was 2×10
−3 molL
−1; the initial concentration of Ce(IV)
was 2×10
−3 molL
−1,p H ~ 4
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methoxy-2-acetyl-naphthalene shows the emission band
centered at around 440 nm [17] ,w h i c hc o r r e s p o n dt ot h e
chemiluminescent spectrum.
Analytical Application
The reaction mixture of NP-Ce(IV)-Eu(III) was used for the
determination of the naproxen concentration, with applying
the cut-off filters method. A linear dependence of the CL
light intensity sums of the reaction system on the NP
concentration, with the use of a filter transmitting emission
of l>585 nm, was obtained in the NP concentration range
of 4×10
−8 molL
−1 (9 ng/mL) to 2×10
−6 molL
−1(460 ng/
mL) (correlation cofficient r=0.9998) with the detection
limit of 1.1×10
−8 molL
−1 (2.5 ng/mL). It is six times lower
than determination in reaction system without europium(III)
ions [18].
Interference
The effect of some common inorganic ion and excipient
species on the determination of 2.0×10
−7 molL
−1 naproxen
solution was studied. The tolerance limit was taken as the
recovery in the range 95%–105%. The tolerance ratios were
as follows: 5000-fold for indomethacin, ibuprofen, K(I), Na
(I),Mg(II),Ca(II);Zn(II);NO3
−,S O 4
2−; 500-fold for CO3
2−;
100-fold for Fe(III) starch, glycine, glucose; and 30-fold for
Fe(II). These tolerance ratios were higher than in system
without europium(III) ions [18].
Applications
The proposed method was applied to the determination of
Naproxen in commercially available pharmaceuticals. The
obtained results are shown in Table 1. As can be seen, there
are no significant differences between the labeled values
and those obtained by the suggested method. A mean
recovery values were in the range 98–104%.
The accuracy studies for the determination of naproxen
in human urine were conducted with three known concen-
trations of the compound. Results of recovery studies for
urine are given in Table 2. Each value represents the mean
of five measurements.
Conclusion
The reaction system NSAID-Ce(IV) belongs to the group
systems generating ultra-weak emission characteristic for
excited carbonyl species formed as a result of NSAID
oxidation. The presence of Eu(III) ions into the systems of
IB-Ce(IV) and IM-Ce(IV) did not influence on CL
intensity, however the Eu(III) ions are effective activators
in the NP-Ce(IV) system. The CL reaction system of NP-
Ce(IV)-Eu(III), as these studies have shown, can be
analytically useful. This method gives a lower detection
limit and a large tolerance of on the presence of inorganic
ion and excipient species compared with the NP-Ce(IV)
system. The proposed chemiluminescent method, based on
emission of the Eu(III) ions in the NP-Ce(IV)-Eu(III)
system, is simple, accurate and precise and allows the
determination of naproxen in pharmaceutical preparations
and in human urine.
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Table 1 Determination of naproxen in commercial formulations with
the proposed CL method (n=5)
Drug sample Label
Amount (mg)
Found by proposed
method (mg±S.D.)
Recovery [%]
APO-NAPROXEN 250 mg 249±3 99.6±1.2
ALEVE 220 mg 223±4 101.4±1.8
NAPROXEN 500 mg 495.5±7 99.1±1.4
NAPROXEN 250 mg 255.3±3 102.1±1.2
NAPROXEN EMO gel 100 mg g
−1 101.8±2 mg g
−1 101.8±2
Sample Added
a (μg/ml) Found±SD ((μg/ml) Recovery±SD (%)
Urine-1 2 2.04±0.04 102±2
4 4.02±0.06 100.5±1.5
10 9.82±0.16 98.2±1.6
Urine-2 2 1.98±0.04 99±2
6 6.02±0.07 100.3±1.2
14 14.30±0.15 102.1±1.1
Table 2 Determination of nap-
roxen. in human urine with the
proposed CL method
ain undiluted urine
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Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
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